Literature DB >> 10445014

Clinical highlights from the National Cancer Data Base, 1999.

A M Fremgen1, K I Bland, L S McGinnis, H J Eyre, C J McDonald, H R Menck, G P Murphy.   

Abstract

The National Cancer Data Base (NCDB), a joint project of the Commission on Cancer of the American College of Surgeons and the American Cancer Society, collects and analyzes data from a wide variety of sources throughout the United States, including small community hospitals. Due to this unique reporting system, individual facilities can compare their own data with the aggregate data from the NCDB, using their findings to evaluate local patient care practices. This article highlights the principal findings of the NCDB and Patient Care Evaluation articles published in 1998 on breast, prostate, cervical, endometrial, gallbladder, head and neck, nasopharyngeal, rectal, thyroid, and vaginal cancers, as well as on melanoma, brain tumors, and Hodgkin's disease. With more than five million cancer cases in the NCDB for the years between 1985 and 1995, sufficient numbers of even rare cancers have been accrued to permit some types of epidemiologic and clinical assessments.

Entities:  

Mesh:

Year:  1999        PMID: 10445014     DOI: 10.3322/canjclin.49.3.145

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  17 in total

1.  Racial Disparities in Treatment Patterns and Survival Among Surgically Treated Malignant Pleural Mesothelioma Patients.

Authors:  Naomi Alpert; Maaike van Gerwen; Meredith Steinberg; Nisha Ohri; Raja Flores; Emanuela Taioli
Journal:  J Immigr Minor Health       Date:  2020-12

2.  Transoral surgery using a novel single-port flexible endoscope system.

Authors:  Magis Mandapathil; Brandon Greene; Thomas Wilhelm
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-07-14       Impact factor: 2.503

3.  Salvage surgery for head and neck squamous cell carcinoma.

Authors:  Magis Mandapathil; Marion Roessler; Jochen A Werner; Carl E Silver; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-23       Impact factor: 2.503

4.  Role of excision repair cross-complementation 1 expression as a prognostic marker for response to radiotherapy in early-stage laryngeal cancer.

Authors:  Kimberly Johung; Amar Rewari; Hao Wu; Benjamin Judson; Joseph N Contessa; Bruce G Haffty; Roy H Decker
Journal:  Head Neck       Date:  2012-06-28       Impact factor: 3.147

5.  Diagnostic laparoscopy for periampullary and pancreatic cancer: what is the true benefit?

Authors:  Christopher J Barreiro; Keith D Lillemoe; Leonidas G Koniaris; Taylor A Sohn; Charles J Yeo; JoAnn Coleman; Elliot K Fishman; John L Cameron
Journal:  J Gastrointest Surg       Date:  2002 Jan-Feb       Impact factor: 3.452

6.  Skin cancer risk perceptions: a comparison across ethnicity, age, education, gender, and income.

Authors:  Kesha J Buster; Zhiying You; Mona Fouad; Craig Elmets
Journal:  J Am Acad Dermatol       Date:  2011-08-27       Impact factor: 11.527

7.  Prognostic factors of survival in patients with malignant pleural mesothelioma: an analysis of the National Cancer Database.

Authors:  Maaike Van Gerwen; Naomi Alpert; Andrea Wolf; Nisha Ohri; Erik Lewis; Kenneth E Rosenzweig; Raja Flores; Emanuela Taioli
Journal:  Carcinogenesis       Date:  2019-06-10       Impact factor: 4.944

8.  BCCIP as a prognostic marker for radiotherapy of laryngeal cancer.

Authors:  Amar Rewari; Huimei Lu; Rahul Parikh; Qifeng Yang; Zhiyuan Shen; Bruce G Haffty
Journal:  Radiother Oncol       Date:  2008-11-27       Impact factor: 6.280

Review 9.  Early operable breast cancer.

Authors:  A C Wolff; N E Davidson
Journal:  Curr Treat Options Oncol       Date:  2000-08

10.  Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer.

Authors:  Magis Mandapathil; Miroslaw J Szczepanski; Marta Szajnik; Jin Ren; Diana E Lenzner; Edwin K Jackson; Elieser Gorelik; Stephan Lang; Jonas T Johnson; Theresa L Whiteside
Journal:  Clin Cancer Res       Date:  2009-10-13       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.